‘Boomerang’ Londoners return to a city ‘on the brink of reinvention’ April 30, 2024 London's culture is drawing residents who left the city during the pandemic back to the capital.
Glencore expects strong year from trading arm but reports lower copper output April 30, 2024 lencore reported total copper production of about 239,700 tonnes for the first quarter, compared to 244,100 tonnes a year earlier. It said cobalt production was down due to lower output at its Mutanda mine in Congo.
Challenging macro backdrop weighs on kitchen giant Howden’s first quarter numbers April 30, 2024 "We have made an encouraging start to the year with trading in line with our expectations. We are also continuing to make good progress in implementing our strategic initiatives which drive profitable growth,” Howdens Chief Executive Andrew Livingston said.
Coca-Cola HBC hit by exchange rate headwinds despite sales growth April 30, 2024 The bottling giant said revenue only grew by one per cent in the quarter, primarily due to foreign exchange turbulence, the company said.
Luxury fashion brands struggle to compete with celebs in the branded beauty craze April 28, 2024 “There has been a massive shift; we are inundated with brands now. The selectivity is really the main challenge,” Clare Horner, group beauty director at UK luxury department store Harvey Nichols.
Is there enough student housing for the next cohort of school leavers in September? April 27, 2024 “It’s a good time to enter the market,” Jay Ahluwalia, principal director of Dominus, said. Dominus, which previously focused on hotels and real estate, currently has two student builds in development in London.
Bottoms up: Central London set for a new rooftop bar as Maven Leisure raises £2m April 25, 2024 Maven plans to raise the money via the private equity investment firm Growthdeck, which offers “tax-efficient investment opportunities in UK growth businesses”.
US regulator accepts GSK’s application to expand treatment of cancer drug April 24, 2024 The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.
Angle agrees deal with Astrazeneca for tech to kill cancer cells April 24, 2024 This is expected to be driven by an increase in the use of combination therapy for the treatment of drug-resistant cancers and the need for novel targeted medicines for cancer treatment.
The luxury watch market bubble has burst. What next for Rolex, Patek Philippe and Audemars? April 20, 2024 The pandemic-era boom, which saw luxury watch prices rise by 20 per cent in just the fourth quarter of 2021, is now over.